Running away from cardiovascular disease at the right speed : the impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes

Abstract
Higher levels of physical activity (PA) and cardiorespiratory fitness (CRF) are associated with lower risk of incident cardiovascular disease (CVD). However, the relationship of aerobic PA and CRF with risk of atherosclerotic CVD outcomes and heart failure (HF) seem to be distinct. Furthermore, recent studies have raised concerns of potential toxicity associated with extreme levels of aerobic exercise, with higher levels of coronary artery calcium and incident atrial fibrillation noted among individuals with very high PA levels. In contrast, the relationship between PA levels and measures of left ventricular structure and function and risk of HF is more linear. Thus, personalizing exercise levels to optimal doses may be key to achieving beneficial outcomes and preventing adverse CVD events among high risk individuals. In this report, we provide a comprehensive review of the literature on the associations of aerobic PA and CRF levels with risk of adverse CVD outcomes and the preceding subclinical cardiac phenotypes to better characterize the optimal exercise dose needed to favorably modify CVD risk.
Main Authors
Format
Articles Review article
Published
2020
Series
Subjects
Publication in research information system
Publisher
Elsevier
The permanent address of the publication
https://urn.fi/URN:NBN:fi:jyu-202012167200Käytä tätä linkitykseen.
Review status
Peer reviewed
ISSN
0033-0620
DOI
https://doi.org/10.1016/j.pcad.2020.11.004
Language
English
Published in
Progress in Cardiovascular Diseases
Citation
  • Mehta, A., Kondamudi, N., Laukkanen, J. A., Wisloff, U., Franklin, B. A., Arena, R., Lavie, C. J., & Pandey, A. (2020). Running away from cardiovascular disease at the right speed : the impact of aerobic physical activity and cardiorespiratory fitness on cardiovascular disease risk and associated subclinical phenotypes. Progress in Cardiovascular Diseases, 63(3), 762-774. https://doi.org/10.1016/j.pcad.2020.11.004
License
CC BY-NC-ND 4.0Open Access
Additional information about funding
Dr. Pandey is supported by the Texas Health Resources Clinical Scholarship. Dr. Mehta is supported by American Heart Association postdoctoral fellowship award 19POST34400057.
Copyright© 2020 Elsevier

Share